The Role of the Epidermal Growth Factor Receptor Family in Mammary Tumorigenesis and Metastasis
- 25 November 1999
- journal article
- review article
- Published by Elsevier BV in Experimental Cell Research
- Vol. 253 (1), 78-87
- https://doi.org/10.1006/excr.1999.4706
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapySeminars in Cancer Biology, 1999
- Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasiaBioEssays, 1999
- neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group.Journal of Clinical Oncology, 1998
- Detection of amphiregulin and Cripto-1 in mammary tumors from transgenic miceMolecular Carcinogenesis, 1996
- Epidermal growth factor-related peptides in the pathogenesis of human breast cancerBreast Cancer Research and Treatment, 1994
- Neu and its ligands: From an oncogene to neural factorsBioEssays, 1993
- Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors.Proceedings of the National Academy of Sciences of the United States of America, 1989
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987